AbbVie upgraded, Biogen downgraded as HSBC reflects on 2026 in pharma
Source: SeekingAlpha
2025-12-10 10:34:46 ET
More on Biogen, AbbVie
- AbbVie Inc. (ABBV) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript
- Biogen Inc. (BIIB) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript
- Biogen Inc. (BIIB) Presents at Evercore 8th Annual Healthcare Conference Transcript
- CMS unveils price reductions for 15 drugs for 2027
- AbbVie, Genmab win FDA label expansion for Epkinly in follicular lymphoma
Read the full article on Seeking Alpha
For further details see:
AbbVie upgraded, Biogen downgraded as HSBC reflects on 2026 in pharma
Novartis AG
NASDAQ: NVS
NVS Trading
-0.22% G/L:
$143.06 Last:
198,267 Volume:
$142.47 Open:
NVS Latest News
February 24, 2026 04:52:00 pm
Could Novartis Stock Quietly Help You Build a Millionaire Retirement Portfolio?
NVS Stock Data
$303,205,301,793
1,889,070,162
N/A
868
N/A
Pharmaceuticals
Healthcare
CH
Basel
